Economic burden of inpatients infected with Klebsiella pneumoniae carbapenemase

OBJECTIVE: To estimate the direct medical costs of drug therapy of Klebsiella pneumoniae carbapenemase (KPC) infection patients in hospital-based context. METHODS: A cost-of-illness study conducted with a prospective cohort design with hospitalized adults infected by KPC. Data collection was perform...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Wendel Mombaque, Secoli, Silvia Regina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2019
Materias:
Health Economics and Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533035/
https://www.ncbi.nlm.nih.gov/pubmed/31116310
http://dx.doi.org/10.31744/einstein_journal/2019GS4444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533035/
https://www.ncbi.nlm.nih.gov/pubmed/31116310
http://dx.doi.org/10.31744/einstein_journal/2019GS4444

Ejemplares similares